Barbara C. Tilley

Social Security Office (Thailand) — Thailand

Medicine · Health Sciences

61h-index29.4kcitations243works1.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Parkinson's Disease Mechanisms and Treatments(42), Health Systems, Economic Evaluations, Quality of Life(32), Acute Ischemic Stroke Management(31), Statistical Methods in Clinical Trials(26), Neurological disorders and treatments(17)

Publications238 total

On the Readiness of Enterprise-Scale Log Analysis Solutions Against Advanced Persistent Threats
2025
Validation of the Portuguese <scp>MDS</scp>‐<scp>UPDRS</scp>: Challenges to Obtain a Scale Applicable to Different Linguistic Cultures
Movement Disorders Clinical Practice·2024· 2 citedOpen Access
The difference between concealment and blinding in clinical trials and why both are important. A reply to Garg and Mickenautsch, BMC Medical Research Methodology (2022) 22:17
BMC Medical Research Methodology·2023· 1 citedOpen Access
1588 INTRODUCING ‘THE CARE TOOL’: A SIMPLE TOOL TO IMPROVE GENERAL SURGERY DOCUMENTATION AND UNDERSTANDING OF KEY ASPECTS OF FRAILTY
Age and Ageing·2023Open Access
Study in Parkinson’s disease of exercise phase 3 (SPARX3): study protocol for a randomized controlled trial
Trials·2022· 32 citedOpen Access
Inclusion of <scp>Non–English‐Speaking</scp> Participants in Studies of Parkinson's Disease: A Call to Action
Movement Disorders·2022· 2 citedOpen Access
Semiparametric regression modeling of the global percentile outcome
Journal of Statistical Planning and Inference·2022· 1 citedOpen Access
Brooke, Emma Frances
2022
Using increased trust in medical researchers to increase minority recruitment: The RECRUIT cluster randomized clinical trial
Contemporary Clinical Trials·2021· 27 citedOpen Access
Brooke, Emma Frances
2020
Intent-to-treat analysis of cluster randomized trials when clusters report unidentifiable outcome proportions
Clinical Trials·2020· 6 citedOpen Access
Cost‐effectiveness evaluation of the <scp>PROPPR</scp> trial transfusion protocols
Transfusion·2020· 4 citedOpen Access
Older Blood Is Associated With Increased Mortality and Adverse Events in Massively Transfused Trauma Patients: Secondary Analysis of the PROPPR Trial
Annals of Emergency Medicine·2018· 57 citedOpen Access
Recruitment of racial and ethnic minorities to clinical trials conducted within specialty clinics: an intervention mapping approach
Trials·2018· 65 citedOpen Access
Validation of the Hebrew version of the Movement Disorder Society—Unified Parkinson's Disease Rating Scale
Parkinsonism & Related Disorders·2017· 17 citedOpen Access
Benefits of stroke treatment delivered using a mobile stroke unit trial
International Journal of Stroke·2017· 61 citedOpen Access
Autonomic and electrocardiographic findings in Parkinson's disease
Autonomic Neuroscience·2017· 34 citedOpen Access
Design of a cluster-randomized minority recruitment trial: RECRUIT
Clinical Trials·2017· 41 citedOpen Access
Earlier Endpoints are Required for Hemorrhagic Shock Trials Among Severely Injured Patients
Shock·2017· 183 citedOpen Access
Caffeine, creatine, GRIN2A and Parkinson's disease progression
Journal of the Neurological Sciences·2017· 33 citedOpen Access
page 1 of 12Next →

Frequent Co-authors

Thomas Brott(11), Steven R. Levine(11), Christopher G. Goetz(10), Glenn T. Stebbins(10), James C. Grotta(9), John R. Marler(9), Joseph P. Broderick(9), Patrick D. Lyden(8), Mei Lü(8), Thomas Kwiatkowski(7), Michael Frankel(6), Pablo Martínez‐Martín(5), Carlos Singer(5), Jing Huang(5), Werner Poewe(4), Anette Schrag(4), John B. Holcomb(4), Erin E. Fox(4), E. Clarke Haley(4), Carmen Rodríguez‐Blázquez(4)